statement

此舉令香港成為亞洲首個推行組織碎化技術(Histotripsy)腎臟癌臨床試驗的城市。

A statement by 李嘉誠基金會. Statements are as reported by the cited publishers — not verified by DecisionGateway.

令香港成為亞洲首個推行組織碎化技術(Histotripsy)腎臟癌臨床試驗的城市
rthk_new_cPublished 2026-11-11 Read source

Discussion

0/2000

Related claims

More claims by 李嘉誠基金會

All claims by 李嘉誠基金會